# Somerset Therapeutics Limited – FDA Inspection, Apr 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/b1b4a187-743e-4022-9e45-599bd353be3b
Source feed: FDA_Inspections

> FDA inspection 1017014 of Somerset Therapeutics Limited, April 24, 2017. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017014
- Company Name: Somerset Therapeutics Limited
- Inspection Date: 2017-04-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1261727 - 2025-02-21](https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/fe96a3fc-4617-4a2b-83f9-bbbc164238f5)
- [FDA Inspection 1226714 - 2023-10-27](https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/12a7816c-5ee0-4c43-b66d-631bccf96afa)
- [FDA Inspection 1166834 - 2022-04-04](https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/81ffbd04-e1df-4ac2-a152-50b2ecde316a)
- [FDA Inspection 1118121 - 2020-02-19](https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/3076e44f-4a10-4b2a-a55c-b3a3d9749b53)
- [FDA Inspection 1097269 - 2019-07-23](https://www.keypedia.com/records/fda_inspections/somerset-therapeutics-limited/ad71e53a-bcc5-49ae-9f2a-fde4cfe64916)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nicholas-a-violand/c0c3ee7a-8adb-43d2-974c-06220ef8e8eb)

Company: https://www.keypedia.com/companies/somerset-therapeutics-limited/cdfeb30a-e26b-4be1-9ca9-8aaf6434d0a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
